HomeCompareCTT vs JNJ

CTT vs JNJ: Dividend Comparison 2026

CTT yields 45.85% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTT wins by $286.9K in total portfolio value
10 years
CTT
CTT
● Live price
45.85%
Share price
$10.37
Annual div
$4.75
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$317.3K
Annual income
$59,988.51
Full CTT calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CTT vs JNJ

📍 CTT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTT
Annual income on $10K today (after 15% tax)
$3,897.54/yr
After 10yr DRIP, annual income (after tax)
$50,990.23/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, CTT beats the other by $46,952.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTT + JNJ for your $10,000?

CTT: 50%JNJ: 50%
100% JNJ50/50100% CTT
Portfolio after 10yr
$173.9K
Annual income
$32,369.20/yr
Blended yield
18.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CTT
Analyst Ratings
3
Buy
4
Hold
Consensus: Hold
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTT buys
0
JNJ buys
0
No recent congressional trades found for CTT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTTJNJ
Forward yield45.85%2.14%
Annual dividend / share$4.75$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$317.3K$30.5K
Annual income after 10y$59,988.51$4,749.88
Total dividends collected$247.9K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: CTT vs JNJ ($10,000, DRIP)

YearCTT PortfolioCTT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$15,285$4,585.34$10,594$274.49+$4.7KCTT
2$22,906$6,550.33$11,294$360.69+$11.6KCTT
3$33,683$9,173.75$12,133$476.91+$21.6KCTT
4$48,648$12,607.49$13,156$635.42+$35.5KCTT
5$69,071$17,017.75$14,432$854.61+$54.6KCTT
6$96,488$22,581.34$16,056$1,162.76+$80.4KCTT
7$132,723$29,480.87$18,175$1,604.53+$114.5KCTT
8$179,912$37,899.19$21,009$2,252.68+$158.9KCTT
9$240,520$48,013.38$24,911$3,229.73+$215.6KCTT
10$317,344$59,988.51$30,458$4,749.88+$286.9KCTT

CTT vs JNJ: Complete Analysis 2026

CTTStock

As of September 14, 2022, CatchMark Timber Trust, Inc. was acquired by PotlatchDeltic Corporation. CatchMark (NYSE: CTT) seeks to deliver consistent and growing per share cash flow from disciplined acquisitions and superior management of prime timberlands located in high demand U.S. mill markets. Concentrating on maximizing cash flows throughout business cycles, the company strategically harvests its high-quality timberlands to produce durable revenue growth and takes advantage of proximate mill markets, which provide a reliable outlet for merchantable inventory. Headquartered in Atlanta and focused exclusively on timberland ownership and management, CatchMark began operations in 2007 and owns interests in 1.5 million acres* of timberlands located in Alabama, Florida, Georgia, North Carolina, Oregon, South Carolina and Texas.

Full CTT Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CTT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTT vs SCHDCTT vs JEPICTT vs OCTT vs KOCTT vs MAINCTT vs ABBVCTT vs MRKCTT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.